BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 24314853)

  • 1. A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
    Juul SE; Comstock BA; Wadhawan R; Mayock DE; Courtney SE; Robinson T; Ahmad KA; Bendel-Stenzel E; Baserga M; LaGamma EF; Downey LC; Rao R; Fahim N; Lampland A; Frantz ID; Khan JY; Weiss M; Gilmore MM; Ohls RK; Srinivasan N; Perez JE; McKay V; Vu PT; Lowe J; Kuban K; O'Shea TM; Hartman AL; Heagerty PJ;
    N Engl J Med; 2020 Jan; 382(3):233-243. PubMed ID: 31940698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use.
    Perrone S; Lembo C; Gironi F; Petrolini C; Catalucci T; Corbo G; Buonocore G; Gitto E; Esposito SMR
    Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Effect in Neurological Recovery via Anti-Apoptotic Akt Signaling in Umbilical Cord Blood and Erythropoietin Combination Therapy for Neonatal Hypoxic-Ischemic Brain Injury.
    Choi JI; Choi JW; Shim KH; Choung JS; Kim HJ; Sim HR; Suh MR; Jung JE; Kim M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage.
    Song J; Wang Y; Xu F; Sun H; Zhang X; Xia L; Zhang S; Li K; Peng X; Li B; Zhang Y; Kang W; Wang X; Zhu C
    CNS Drugs; 2021 Jun; 35(6):681-690. PubMed ID: 33959935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of high and low dose recombinant human erythropoietin on neurodevelopment of premature infants: A meta-analysis.
    Qin N; Qin H
    Medicine (Baltimore); 2021 May; 100(18):e25805. PubMed ID: 33950982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin-induced cluster of seizures in two children with cerebral palsy.
    Tatlı B; Bozgan D; Ekici B; Gürbüzer CA
    Acta Neurol Belg; 2020 Aug; 120(4):969-970. PubMed ID: 31555981
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant Human Erythropoietin Augments Neovascularization Responses in a Neonatal Rat Model of Premature Brain Damage by Phosphatidylinositol 3 Kinase/Akt Pathway.
    Yu DF; Zhu LH; Jiang L
    Chin Med J (Engl); 2017 Apr; 130(7):854-858. PubMed ID: 28345550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.
    Rangarajan V; Juul SE
    Pediatr Neurol; 2014 Oct; 51(4):481-8. PubMed ID: 25266611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of gross motor function in extremely low birth weight children with cerebral palsy at 18 months of age.
    Vohr BR; Msall ME; Wilson D; Wright LL; McDonald S; Poole WK
    Pediatrics; 2005 Jul; 116(1):123-9. PubMed ID: 15995042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of the synergistic effects of cord blood cells and erythropoietin combination therapy after additional cord blood infusion in children with cerebral palsy: 1-year open-label extension study of randomized placebo-controlled trial.
    Suh MR; Min K; Cho KH; Kim J; Lim I; Park M; Noh EM; Kim MY
    Stem Cell Res Ther; 2023 Dec; 14(1):362. PubMed ID: 38087394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can a six-week exercise intervention improve gross motor function for non-ambulant children with cerebral palsy? A pilot randomized controlled trial.
    Bryant E; Pountney T; Williams H; Edelman N
    Clin Rehabil; 2013 Feb; 27(2):150-9. PubMed ID: 22850757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of erythropoietin on neurodevelopment in infants with cerebral palsy: a pilot study.
    Lee HS; Song J; Min K; Choi YS; Kim SM; Cho SR; Kim M
    Brain Dev; 2014 Oct; 36(9):764-9. PubMed ID: 24314853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.
    Min K; Song J; Kang JY; Ko J; Ryu JS; Kang MS; Jang SJ; Kim SH; Oh D; Kim MK; Kim SS; Kim M
    Stem Cells; 2013 Mar; 31(3):581-91. PubMed ID: 23281216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of GMFM-88 and GMFM-66 to detect changes in gross motor function in children with cerebral palsy (CP): a literature review.
    Alotaibi M; Long T; Kennedy E; Bavishi S
    Disabil Rehabil; 2014; 36(8):617-27. PubMed ID: 23802141
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.